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Abstract
Background: Mitral regurgitation (MR) is common in patients with dilated cardiomyopathy (DCM). It is unknown 
whether the criteria for MR classification are inadequate for patients with DCM. 
Objective: We aimed to evaluate the agreement among the four most common echocardiographic methods for MR 
classification.
Methods: Ninety patients with DCM were included. Functional MR was classified using four echocardiographic methods: 
color flow jet area (JA), vena contracta (VC), effective regurgitant orifice area (ERO) and regurgitant volume (RV). MR was 
classified as mild, moderate or important according to the American Society of Echocardiography criteria and by dividing 
the values into terciles. The Kappa test was used to evaluate whether the methods agreed, and the Pearson correlation 
coefficient was used to evaluate the correlation between the absolute values of each method.
Results: MR classification according to each method was as follows: JA: 26 mild, 44 moderate, 20 important; VC: 12 mild, 
72 moderate, 6 important; ERO: 70 mild, 15 moderate, 5 important; RV: 70 mild, 16 moderate, 4 important. The agreement 
was poor among methods (kappa = 0.11; p < 0.001). It was observed a strong correlation between the absolute values of 
each method, ranging from 0.70 to 0.95 (p < 0.01) and the agreement was higher when values were divided into terciles 
(kappa = 0.44; p < 0.01) 
Conclusion: The use of conventional echocardiographic criteria for MR classification seems inadequate in patients 
with DCM. It is necessary to establish new cutoff values for MR classification in these patients. (Arq Bras Cardiol. 
2013;101(5):457-465)
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Introduction
Functional mitral regurgitation (MR) is the secondary 
MR to left ventricle (LV) dilation1 and it is often shown in 
patients with dilated cardiomyopathy (DCM), where the 
significant MR occurs in 35-50% of patients with chronic 
heart failure2. It has already been shown that presence and 
severity of a functional MR are independently associated 
with the prognosis in patients with non-ischemic DCM3-5.
The functional MR pathophysiology is different from that 
of the MR by primary valvular disease. Functional MR is the 
result of a complex phenomenon, with displacement of the 
papillary muscles caused by LV dilation, valve ring dilatation 
and tethering of the mitral valve1,6-8. Furthermore, in patients 
with DCM, the left atrium works as a low resistence chamber 
to which the LV can eject blood9.
Although some authors support mitral valve surgery for 
patients with significant functional MR and heart failure, 
it is still controversial the suggestion for surgery in these 
patients10-12. Currently, mitral valve surgery is considered 
as Class IIb for patients with refractory heart failure and 
significant functional MR13.
Doppler echocardiography is the test of choice for the 
noninvasive assessment of MR mechanism and severity14. 
It is unknown whether the recommendations of the 
American Society of Echocardiography (ASE), together 
with the European Society of Cardiology Working Group 
for evaluation and classification of primary valvular 
insufficiency by Doppler echocardiography14 are suitable 
for patients with functional MR and DCM. Additionally, 
the different methods using Doppler echocardiography 
and color flow mapping were validated in clinical studies 
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for patients showing different causes of primary MR15, but 
not specifically for patients with DCM. 
This study aimed to evaluate the agreement for patients with 
DCM, among the four most commonly used echocardiographic 
methods for MR classification.
Methods
Patients
This study included 90 consecutive outpatients with 
non-ischemic DCM and functional MR of a tertiary center 
for treatment of heart failure and cardiomyopathies, of the 
Escola Paulista de Medicina / Universidade Federal de São 
Paulo, from September 2007 to September 2009. Inclusion 
criteria were: age ≥ 18 years old, functional class ≤ III 
(New York Heart Association), medical treatment optimized 
for heart failure, sinus rhythm, LV ejection fraction ≤ 0.40 
(Simpson method modified) and good quality image. 
Patients with primary valvular disease, hypertension, 
coronary artery disease (for epidemiology and/or coronary 
angiography), end stage renal disease or chronic obstructive 
pulmonary disease were excluded. All participants signed 
an informed consent and the institution of ethics committee 
approved the project.
Echocardiography
All subjects performed a ful l  two-dimensional 
echocardiography by using the IE 33 machine (Philips, Andover, 
Massachusetts), equipped with a 2-5 MHz transducer and 
under continuous electrocardiographic monitoring. Patients 
were assessed in left lateral decubitus by an echocardiograph 
qualified-physician, only. LV ejection fraction was calculated 
using the Simpson method modified.
Mitral Regurgitation Echocardiographic Assessment 
MR was assessed by four echocardiographic methods that 
are part of the recommendations of the American Society 
of Echocardiography14: area of the regurgitant jet (RJ), vena 
contracta (VC), effective regurgitant orifice area (ERO) and 
regurgitant volume (RV) by the converging flow method 
(PISA). All methods were assessed at the apical window 
using image zoom.
RJ was measured in the apical 4-chamber view using 
Nyquist limit of 50-60 cm/s, the color gain adjusted to 
exclude artifacts from non-mobile structures (Figure 1). 
VC was measured in the apical 4-chamber view as the 
narrowest MR jet, after the orifice (Figure 1). 
 The converging flow method (proximal isovelocity 
surface area; PISA) was used to calculate the ERO and RV. 
PISA radius was measured using the Nyquist limit at which 
the flow convergence assumed a hemispherical shape 
(Figure 1). ERO was calculated using the formula: 2 x π x R2 
x V aliasing / V peak (R: radius, in cm; V aliasing: proximal 
flow convergence velocity in cm/s, V peak: MR maximum 
velocity in cm/s). RV was calculated using the formula: 
ERO x VTI (VTI: MR jet velocity time integral).
The IM was classified as mild, moderate or important 
using each of the methods described according to the criteria 
and cutoff values of the recommendations of the American 
Society of Echocardiography14. MR was also divided into 
terciles (lower, intermediate and higher values) according to 
the absolute values obtained by each method.
Statistical Analysis
Statistical analysis was performed using the SPSS 13.0 
software (SPSS Inc., Chicago, Illinois). Continuous data are 
shown as mean ± PD and categorical data are described 
in percentages. Pearson correlation coefficient was used to 
assess the correlation between the absolute values of the 
four methods used for MR quantification. Kappa agreement 
test was used to assess the agreement between methods 
used to classify the MR. Significance values of p < 0.05 
were considered.
Results
Clinical Data
Patient clinical basal characteristics are detailed in Table 1. 
From the total 90 patients, 60 (67%) showed idiopathic 
dilated cardiomyopathy and 30 (33%) patients showed Chagas 
cardiomyopathy. Functional class mean was 2.2 ± 0.6. All patients 
were on beta-blockers (carvedilol 76%, 48 ± 6 mg/day, and 
metoprolol 24%, 178 ± 43 mg/day), ACE inhibitors (captopril 
62%, 133 ± 24 mg/day, and enalapril 38%, 31 ± 10 mg/day), 
and furosemide (97 ± 62 mg/day). Eighty-one (90%) patients 
were on spironolactone and 20 (22%) were taking digoxin.
Doppler echocardiography
Doppler echocardiography data are described in Table 2. 
LV ejection fraction average was 0.30 ± 0.07 and 24 (27%) 
patients showed restrictive filling pattern. The E/e’ ratio was 
18.0 ± 7.9 and the mean systolic pulmonary pressure was 
44 ± 13 mmHg.
Mitral Regurgitation - Echocardiographic Data 
The mean values for each method were: RJ: 6.8 ± 4.1 cm2, 
VC: 0.44 ± 0.15 cm; ERO: 0.14 ± 0.10 cm2, and 
RV: 22.1 ± 15.3 ml (Table 3). The MR jets were central 
in all patients, as expected. Pearson calculated correlation 
coefficient (r) indicated a strong correlation between the 
absolute values of each method, ranging from 0.70 to 0.95 
(p < 0.01) (Figure 2).
According to the cutoff values of the recommendations 
of the American Society of Echocardiography, MR was 
classified by the RJ method as mild in 26 patients, moderate 
in 44 patients and important in 20 patients. Through the 
VC, MR was considered mild in 12 patients, moderate in 
72 patients and important in 6 patients. Through the ERO, 
70 patients showed mild MR, 15 patients moderate MR 
and 5 patients important MR. Through the RV, MR was 
mild in 70 patients, moderate in 16 patients and important 
in 4 patients (Figure 3). The agreement among the four 
methods evaluated was poor (kappa = 0.11, p <0.01).
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Figure 1 - Mitral regurgitation assessment using four echocardiographic methods in a patient with idiopathic dilated cardiomyopathy. A) Mitral regurgitation jet area 
measurement showing an area of 9.01 cm2; B) Vena contracta measurement (0.40 cm), in; C/D) Magnified image of the measure of hemisphere radius, maximum velocity 
and VTI for calculation of effective regurgitant orifice area and regurgitant volume. In this patient, the effective regurgitant orifice area was 0.14 cm2 and the regurgitant 
volume was 23.8 ml.
Twenty patients with important MR by the RJ showed the 
same LV ejection fraction as the other patients (28.04 ± 5.21 
vs. 31.01 ± 7.79, p = 0.11). 
The absolute values of each method were divided into terciles: 
30 lower values, 30 intermediate values and 30 higher values 
(Figure 4). The cutoff values that divided the terciles were different 
from the cutoff values of the American Society of Echocardiography. 
With the cutoff values used to divide into terciles for the MR 
classification in each method, we observed a better agreement 
among the methods (kappa = 0.44, p <0.01). Figure 5 shows the 
MR classification box-plots according to the cutoff values of the 
American Society of Echocardiography and the terciles. 
Discussion
The main finding of this study is the poor ruim agreement 
among the quantitative echocardiographic methods for MR 
classification in patients with DCM, using the criteria and 
cutoff values of the American Society of Echocardiography. 
The MR evaluation and classification remains a challenge, 
even in patients with primary valvular disease, which has been 
the reason for recent publications15-18. This is the first study to 
address the MR classification by different echocardiographic 
methods in patients with DCM. A previous study, which 
Table 1 – Patient Basal Clinical Features
N = 90 patients
Age (years) 53 ± 11
Male (%) 70
BSA (kg/m²) 1.73 ± 0.17
HR (bpm) 69 ± 12
SBP (mmHg) 109 ± 20
DBP (mmHg) 69 ± 14
Cardiomyopathy 60 (67%)
Idiopathic Dilated
Cardiomyopathy (%) 30 (33%)
Chagas (%)
Functional Class 
(NYHA) 2.2 ± 0.6
FC I 7 (8%)
FC II 55 (61%)
FC III 28 (31%)
Values expressed as mean ± standard deviation or frequency (%).
BSA: body surface area; FC: functional class; HR: heart rate; NYHA: New York 
Heart Association; DBP: diastolic blood pressure; SBP: systolic blood pressure.
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Figure 2 - Scatter charts for the correlation between absolute values for each of the four methods used for Mitral Regurgitation classification (p < 0.01). RJ: regurgitant 
jet area; ERO: effective regurgitant orifice area; VC: vena contracta; RV: regurgitant volume.
included patients with myxomatous or rheumatic etiology 
MR, unlike our study, showed a good agreement between 
the quantitative echocardiographic methods15.
Although we have observed a good correlation between the 
absolute values of each method, there was a poor agreement 
in the MR classification. The highest correlation was between 
the ERO and RV, as expected, since both measures derives 
from PISA method. These findings suggest that the main reason 
for the poor agreement between the methods is that, although 
the cutoff values of the American Society of Echocardiography 
are appropriate for patients with primary valvular disease15, 
they are inadequate for patients with functional MR and DCM. 
The best agreement observed when using different cutoff values, 
based on the division into terciles, reinforces this hypothesis. 
Further studies are required to establish specific cutoff values for 
the classification of functional MR in patients with DCM.
Functional Mitral Regurgitation: Echocardiographic 
Assessment Mechanisms
Differences between the pathophysiological mechanisms 
of primary and functional MR6,7, as well as particularities of 
Table 2 – Doppler echocardiography data
N = 90 patients
LA Diameter 46 ± 6 mm
LAVi 54 ± 19 ml/m2
LVEDV 273 ± 100 ml
LVESV 194 ± 84 ml
LVEF 30.4 ± 7.4 %
E Wave Velocity 79.5 ± 29.7 cm/s
A Wave Velocity 65.6 ± 31.9 cm/s
E/A ratio 1.4 ± 1.5
Restrictive filling standard 27 %
e’ septal Wave Velocity 4.8 ± 1.8 cm/s
E/e’ ratio 18.0 ± 7.9
PASP 44 ± 13 mmHg
Values expressed as mean ± standard deviation or frequency (%).
LA: left atrium; LVEF: left ventricle ejection fraction; PASP: pulmonary artery 
systolic pressure; LAVi: left atrial volume indexed by surface area; LVEDV: left 
ventricle end-diastolic volume; LVESV: left ventricle end-systolic volume.
Table 3 – Mitral regurgitation data (n = 90 patients)
Values Range
Jet Area 6.8 ± 4.1 cm2 1.3 – 19 cm2
Vena contracta 0.44 ± 0.15 cm 0.13 – 0.94 cm
ERO 0.14 ± 0.10 cm2 0.02 – 0.61 cm2
RV 22.1 ± 15.3 ml 4.5 – 83.4 ml
Values expressed as mean ± standard deviation 
ERO: effective regurgitant orifice area; RV: regurgitant volume. 
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Figure 3 – Mitral Regurgitation classification using the four methods described in the study, according to the cutoff values of the American Society of Echocardiography. 
There was a poor agreement between the methods; kappa: 0.11, p < 0.01. RJ: regurgitant jet area; ERO: effective regurgitant orifice area; VC: vena contracta; 
RV: regurgitant volume.
echocardiographic techniques may also have contributed 
to the discrepancies in the MR classification observed in 
this study.
The structural changes that occur in the mitral valve 
apparatus are different among patients with MR and those 
with primary MR and those with functional MR by DMC. 
In functional MR, there is a posterolateral and apical 
displacement of the papillary muscle, apical tethering 
of the valve cusps, and reduced mobility19. Recently, 
with the use of three-dimensional transesophageal 
echocardiography, Matsumara et al. demonstrated that 
PISA geometry is different for patients with DCM, where 
the converging flow zone radius is longer in functional 
MR, when compared to the MR per mitral valve prolapse. 
The authors also observed that PISA method underestimates 
the ERO in functional MR16. Previously, an in vitro study 
demonstrated that ERO underestimates PISA when this is 
not hemispherical20. These findings, in part, explain the 
poor agreement between the MR classification methods 
observed in our study, especially for the exceeding MR 
classified as mild by ERO and RV.
Particular technical aspects of Doppler echocardiography 
for each of the methods used for MR quantification should 
also be considered. The frequency of the transducer and 
color gain adjustment may influence the RJ, where the 
method is considered less accurate14,21. In patients with DCM, 
lower LV ejection fraction may also affect the RJ. VC may 
modify with changes in hemodynamic conditions and it is 
different at several times in the cardiac cycle21. Furthermore, 
VC intermediate values do not necessarily correspond 
to moderate MR, since there is a significant overlap of 
values with this method14. In our study, VC classified MR 
classified as moderate in most patients, which may also 
have contributed to the observed poor agreement between 
the methods. ERO and RV by the PISA method may be less 
accurate in patients with DMC due to non-circular ERO that 
occurs in functional MR, besides the irregular shape of the 
convergence flow zone in these patients16. It was recently 
shown that ERO and RV calculated by echocardiography 
are underestimated when compared to these parameters 
obtained by three-dimensional echocardiography and 
nuclear magnetic resonance22. Therefore, the PISA method 
may underestimate ERO and RV in patients with DCM and 
functional MR, which explains the fact that few patients in 
our study have important MR presented according to the 
ERO and RV methods. 
The evaluation of left atrial and LV dimensions provide 
important data for the classification of primary MR14. 
However, in patients with DCM, the dimensions of these 
heart chambers do not provide indirect information about 
MR severity, since the expansion of these cavities is primarily 
by their own cardiomyopathy. 
The criteria for the MR classification have not been validated 
for patients with functional MR and DCM. Although some 
previous studies have considered different cutoff values for MR 
classification by the ERO method in patients with heart failure, 
these values were chosen arbitrarily23,24. Furthermore, only 
patients with functional MR by ischemic cardiomyopathy were 
included in these, condition with MR different mechanisms 
from those of the nonischemic DCM. Also, MR was classified 
only as important and not important by these authors23,24, 
unlike our study in which MR was classified as mild, moderate 
or important, according to the recommendations of the 
American Society of Echocardiography14.
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Figure 4 - Redistribution of absolute values into terciles (30 low values, 30 intermediate values and 30 high values). They are also showing the cutoff values of the 
American Society of Echocardiography. A better agreement was observed when the values that divided terciles were used for mitral regurgitation classification by 
each method (kappa: 0.44, p <0.01). RJ: regurgitant jet area; ERO: effective regurgitant orifice area; ASE: American Society of Echocardiography; VC: vena contracta; 
RV: regurgitant volume.
Finally, the strong correlation finding between absolute 
values of each method, associated with the poor agreement 
in the MR classification when cutoff values of the American 
Society of Echocardiography are used together with the 
previous study, which showed a good agreement in the 
primary MR classification, reinforces the hypothesis that the 
cutoff values for MR classification, although appropriate in 
primary mitral valve diseases, are inadequate to classify the 
MR in DCM patients.
Clinical Implications 
The MR classification in patients with heart failure and 
DCM is important, since the MR degree has prognostic 
and therapeutic value25,26. The functional MR is associated 
with LV volume overload and remodeling26. Additionally, 
the MR contributes to the increase in LV filling pressures 
and in pulmonary pressure27. The MR classification has a 
role for therapeutic decisions in the clinical practice. MR 
decreases with the clinical treatment of heart failure and 
is associated with the improvement in LV hemodynamic 
conditions, and has been used as one of the criteria for 
response to cardiac resynchronization therapy28.
Patients with refractory symptoms of heart failure and 
important MR may be eligible for MR surgical treatment. 
However, clinical studies evaluating mitral valve surgery in these 
patients showed controversial results10-12. These findings may 
reflect the difficulty in classifying the MR, which consequently 
makes the selection of appropriate patients for surgery difficult.
Findings of this study reinforce the need to integrate the 
results of multiple echocardiographic methods used in the MR 
classification. Moreover, it is necessary to establish new cutoff 
values for MR classification, specific to patients with functional 
MR and DCM, since the correct MR classification is important for 
their clinical management. In cases where the two-dimensional 
transthoracic echocardiography provides conflicting data for 
MR assessment, the transesophageal echocardiography is 
recommended for a better assessment of the MR degree29. 
Another possibility in cases of disagreement between methods 
is the use of three-dimensional echocardiography, which seems 
to be a promising method for assessment of mitral regurgitation 
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Figure 5 - Box plot graphs of the MR classification showing absolute values variation according to the cutoff values of the American Society of Echocardiography and the 
terciles. A) regurgitant jet area (RJ), B) vena contracta (VC) C) effective regurgitant orifice area (ERO) and D) regurgitant volume (RV).
by measuring the vena contracta three-dimensionally and 
the regurgitant volume directly, but such measures still need 
validation29. A better MR classification can improve the selection 
of patients to surgical treatment of functional MR. In the near 
future, with the MR percutaneous techniques advances, 
treatment indication for invasive functional MR must increase, 
where it is essential that a reliable MR degree classification is 
available for patient selection.
Limitations
A gold standard test for comparison of the MR classification 
such as cardiac angiography or MRI was not used, but actually, 
there is no true gold standard test for the MR assessment18, which 
makes the MR classification by echocardiography even harder, 
especially when several methods are available and different 
MR mechanisms are involved. Furthermore, it is important to 
observe that variations may occur in the regurgitation intensity 
with range of hemodynamic or load conditions in the same 
patient, as well as the use of medications that modify these 
loading/hemodynamics conditions14.
The study could not establish a new cutoff value for MR 
classification in this specific population. The division of values 
into terciles was only used to test whether the discrepancy was 
due to the inadequacy of the methods or whether it was due to 
the cutoff values recommended for MR classification. A long-term 
prospective study is required, designed specifically for this 
purpose, comparing the MR assessment by other imaging methods 
(angiography or magnetic resonance imaging), in order to establish 
new cutoff values for MR classification in DCM patients.
Conclusion
The echocardiographic criteria for MR classification are 
in disagreement with patients with DCM. It is essential 
to integrate multiple methods in the MR assessment and 
establish new cutoff values for MR classification for this specific 
population, since the correct MR assessment has therapeutic 
and prognostic implications to these patients. 
Author contributions
Conception and design of the research: Mancuso FJN, 
Moisés VA, Poyares D, Campos O; Acquisition of data: 
Mancuso FJN, Almeida DR, Oliveira WA, Brito FS; Analysis 
and interpretation of the data: Mancuso FJN, Moisés VA, 
463
Original Article
Manuso et al.
Classification of functional mitral regurgitation
Arq Bras Cardiol. 2013;101(5):457-465
1. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants 
of the degree of functional mitral regurgitation in patients with systolic 
left ventricular dysfunction: a quantitative clinical study. Circulation. 
2000;102(12):1400-6.
2. Allen LA, Felker GM. Advances in the surgical treatment of heart failure. Curr 
Opin Cardiol. 2008;23(3):249-53.
3. Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic 
significance of mitral regurgitation and tricuspid regurgitation in patients 
with left ventricular systolic dysfunction. Am Heart J. 2002;144(3):524-9.
4. Trichon BH, Felker GM, Shaw LK, Cabell CH, O’Connor CM. Relation of 
frequency and severity of mitral regurgitation to survival among patients 
with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 
2003;91(5):538-43.
5. Patel JB, Borgeson DD, Barnes ME, Rihal CS, Daly RC, Redfield MM. Mitral 
regurgitation in patients with advanced systolic heart failure. J Card Fail. 
2004;10(4):285-91.
6. Otsuji Y, Handschumacher MD, Schwammenthal E, Jiang L, Song JK, 
Guerrero JL, et al. Insights from three-dimensional echocardiography into the 
mechanism of functional mitral regurgitation: direct in vivo demonstration 
of altered leaflet tethering geometry. Circulation. 1997;96(6):1999-2008.
7. Kwan J, Shiota T, Agler DA, Popovic ZB, Qin JX, Gillinov MA, et al. 
Geometric differences of the mitral apparatus between ischemic and dilated 
cardiomyopathy with significant mitral regurgitation: real-time three-
dimensional echocardiography study. Circulation. 2003;107(8):1135-40.
8. Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in 
heart failure: applications, utility, and new horizons. J Am Coll Cardiol. 
2007;50(5):381-96.
9. Bach DS. Nonischemic mitral regurgitation and left ventricular dysfunction. 
In: Lang RM. (editor). Dynamic echocardiography. St Louis, MO: Saunders 
Elsevier; 2010. p. 81-3.
10. Bolling SF, Deeb GM, Brunsting LA, Bach DS. Early outcome of mitral 
valve reconstruction in patients with end-stage cardiomyopathy. J Thorac 
Cardiovasc Surg. 1995;109(4):676-82.
11. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of 
mitral valve annuloplasty on mortality risk in patients with mitral regurgitation 
and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45(3):381-7.
12. DiSalvo TG, Acker MA, Dec GW, Byrne JG. Mitral valve surgery in advanced 
heart failure. J Am Coll Cardiol. 2010;55(4):271-82. 
13. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et 
al; American College of Cardiology Foundation; American Heart Association. 
2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for 
the Diagnosis and Management of Heart Failure in Adults. A Report of the 
American College of Cardiology Foundation/American Heart Association 
Task Force on Practice Guidelines Developed in Collaboration With the 
International Society for Heart and Lung Transplantation. J Am Coll Cardiol. 
2009;53(15):e1-e90. Erratum in: J Am Coll Cardiol. 2009;54(25):2464.
14. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, 
et al; American Society of Echocardiography. Recommendations for evaluation 
of the severity of native valvular regurgitation with two-dimensional and 
Doppler echocardiography. J Am Soc Echocardiogr. 2003;16(7):777-802.
15. Pinheiro AC, Mancuso FJ, Hemerly DF, Kiyose AT, Campos O, de 
Andrade JL, et al. Diagnostic value of color flow mapping and Doppler 
echocardiography in the quantification of mitral regurgitation in patients 
with mitral valve prolapse or rheumatic heart disease. J Am Soc Echocardiogr. 
2007;20(10):1141-8.
16. Matsumara Y, Fukuda S, Tran H, Greenberg NL, Agler DA, Wada N, et al. 
Geometry of the proximal isovelocity surface area in mitral regurgitation by 
3-dimensional color Doppler echocardiography: difference between functional 
mitral regurgitation and prolapse regurgitation. Am Heart J. 2008;155(2):231-8.
17. Marsan NA, Westenberg JJ, Ypenburg C, Delgado V, van Bommel RJ, Roes 
SD, et al. Quantification of functional mitral regurgitation by real-time 3D 
echocardiography: comparison with 3D velocity-encoded cardiac magnetic 
resonance. JACC Cardiovasc Imaging. 2009;2 (11):1245-52.
18. Biner S, Rafique A, Rafii F, Tolstrup K, Noorani O, Shiota T, et al. 
Reproducibility of proximal isovelocity surface area, vena contracta, and 
regurgitant jet area for assessment of mitral regurgitation severity. JACC 
Cardiovasc Imaging. 2010;3(3):235-43.
19. He S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. Integrated 
mechanism for functional mitral regurgitation: leaflet restriction versus 
coapting force: in vitro studies. Circulation. 1997;96(6):1826-34.
20. Utsunomiya T, Ogawa T, Doshi R, Patel D, Quan M, Henry WL, et al. Doppler 
color flow “proximal isovelocity surface area” method for estimating volume 
flow rate: effects of orifice shape and machine factors. J Am Coll Cardiol. 
1991;17(5):1103-11. Erratum in: J Am Coll Cardiol. 1993;21(6):1537.
21. Kizilbash AM, Willett DL, Brickner ME, Heinle SK, Grayburn PA. Effects of 
afterload reduction on vena contracta width in mitral regurgitation. J Am 
Coll Cardiol. 1998;32(2):427-31.
22. Hamada S, Altiok E, Frick M, Almalla M, Becker M, Marx N, et al. Comparison 
of accuracy of mitral valve regurgitation volume determined by three-
dimensional transesophageal echocardiography versus cardiac magnetic 
resonance imaging. Am J Cardiol. 2012;110(7):1015-20.
23. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic 
mitral regurgitation: long-term outcome and prognostic implications with 
quantitative Doppler assessment. Circulation. 2001;103(13):1759-64.
24. Grigioni F, Detaint D, Avierinos JF, Scott C, Tajik J, Enriquez-Sarano M. 
Contribution of ischemic mitral regurgitation to congestive heart failure after 
myocardial infarction. J Am Coll Cardiol. 2005;45(2):260-7.
25. Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated 
cardiomyopathy with mitral regurgitation: decreased survival despite a low 
frequency of left ventricular thrombus. Am Heart J. 1991;122(3 Pt 1):763-71. 
26. Junker A, Thayssen P, Nielsen B, Andersen PE. The hemodynamic and 
prognostic significance of echo-Doppler-proven mitral regurgitation in 
patients with dilated cardiomyopathy. Cardiology. 1993;83(1-2):14-20. 
References
Oliveira WA, Campos O; Statistical analysis: Mancuso FJN; 
Writing of the manuscript: Campos O; Critical revision of the 
manuscript for intellectual content: Moisés VA, Almeida DR, 
Paola AAV, Carvalho ACC, Campos O.
Potential Conflict of Interest
No potential conflict of interest relevant to this article was 
reported.
Sources of Funding
There were no external funding sources for this study.
Study Association
This article is part of the thesis of post doctoral submitted 
by Frederico José Neves Mancuso, from EPM/UNIFESP - Escola 
Paulista de Medicina.
464
Original Article
Manuso et al.
Classification of functional mitral regurgitation
Arq Bras Cardiol. 2013;101(5):457-465
27. Enriquez-Sarano M, Rossi A, Seward JB, Bailey KR, Tajik AJ. Determinants 
of pulmonary hypertension in left ventricular dysfunction. J Am Coll Cardiol 
1997;29(1):153-9.
28. Breithardt OA, Sinha AM, Schwammenthal E, Bidaoui N, Markus KU, Franke 
A, et al. Acute effects of cardiac resynchronization therapy on functional 
mitral regurgitation in advanced systolic heart failure. J Am Coll Cardiol. 
2003;41(5):765-70. Erratum in J Am Coll Cardiol. 2003;41(10):1852.
29. Tarasoutchi F, Montera MW, Grinberg M, Barbosa MR, Piñeiro DJ, Sánchez 
CR, et al; Sociedade Brasileira de Cardiologia. Diretriz brasileira de 
valvopatias - SBC 2011. / I Diretriz Interamericana de Valvopatias - SIAC 
2011. Arq Bras Cardiol. 2011;97(5 supl. 3):1-67.
465
